Article
Factors Predicting the Therapeutic Response to Methotrexate in Japanese Patients with Rheumatoid Arthritis: A Hospital-Based Cohort Study.
Biological & pharmaceutical bulletin - 1 Jan 2018
Hakamata Jun, Kaneko Yuko, Shimizu Mikiko, Yamaoka Kunihiro, Maruyama Junya, Takeuchi Tsutomu, Mochizuki Mayumi, Hashiguchi Masayuki
Abstract excerpt
Methotrexate (MTX) is used widely as a first-line drug for the treatment of rheumatoid arthritis (RA) worldwide. There are large interindividual differences in the therapeutic response to MTX, but it is not known which factors influence them. We therefore investigated predictive factors associated with the therapeutic response to MTX in a hospital-based cohort study. Japanese adult RA outpatients prescribed MTX...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
